Millennium Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18,750
| Closed | -$458K | – | 6405 |
|
|
2024
Q2 | $458K | Buy |
18,750
+15,000
| +400% | +$693K | ﹤0.01% | 4644 |
|
|
2024
Q1 | $269K | Buy |
3,750
+1,250
| +50% | +$174K | ﹤0.01% | 5202 |
|
|
2023
Q4 | $497K | Hold |
2,500
| – | – | ﹤0.01% | 4646 |
|
|
2023
Q3 | $332K | Buy |
+2,500
| New | +$408K | ﹤0.01% | 4877 |
|
|
2023
Q2 | – | Sell |
-2,500
| Closed | -$367K | – | 6588 |
|
|
2023
Q1 | $367K | Buy |
+2,500
| New | +$506K | ﹤0.01% | 4785 |
|
|
2022
Q4 | – | Sell |
-6,250
| Closed | -$1.2M | – | 6950 |
|
|
2022
Q3 | $1.2M | Buy |
+6,250
| New | +$1.18M | ﹤0.01% | 4179 |
|
|
2021
Q4 | – | Sell |
-5,000
| Closed | -$1.24M | – | 7278 |
|
|
2021
Q3 | $1.24M | Buy |
+5,000
| New | +$1.32M | ﹤0.01% | 4448 |
|
|
2021
Q1 | – | Sell |
-1,250
| Closed | -$198K | – | 6417 |
|
|
2020
Q4 | $198K | Sell |
1,250
-1,275
| -50% | -$277K | ﹤0.01% | 4814 |
|
|
2020
Q3 | $650 | Buy |
+2,525
| New | +$560K | ﹤0.01% | 3437 |
|
Millennium Management's RAPT Position: Q1 2026 in Review
Millennium Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 106,671 shares — an estimated $3.61M sold.
Millennium Management first reported a position in RAPT in Q1 2020 and held it in 24 quarters. The position peaked at $15.4M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Millennium Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 106,671 RAPT Therapeutics shares in Q1 2026, an estimated $3.61M.
- Millennium Management first reported a position in RAPT Therapeutics in Q1 2020 and held it in 24 quarters.
- Millennium Management's RAPT Therapeutics position peaked at $15.4M in Q3 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.